BridgeBio Pharma, Inc. <BBIO.O>: H.C. Wainwright raises target price to $120 from $110
BBIO•Related News
SiteOne Landscape Supply Inc <SITE.N>: KeyBanc initiates coverage with overweight rating; target price $145
SITE•
Meta expands Louisiana data center to 5 gigawatts, investment crosses $50 billion
META•
NASDAQ Trade Halt Continues <UCFI.O> Reason Not Available at 06:55 AM
UCFI•
Longeveron says stem cell therapy laromestrocel reduces neuroinflammation in Phase 2a mild Alzheimer’s trial analysis
LGVN•
Ares Management Corp <ARES.N>: BMO raises target price to $128 from $125
ARES•